Skip to main content
. 2011 Nov 15;51(1):52–59. doi: 10.1093/rheumatology/ker335

Table 3.

HLA Class II associations with ACAs

HLA Ctrl, n (%) SSc, n (%) Uncorrected P Corrected P OR (CI95)
DRB1*0101 139 (7.54) 62 (13.96) <0.001 <0.001 1.991 (1.447, 2.739)
DRB1*0701 283 (15.35) 28 (6.31) <0.001 <0.001 0.373 (0.248, 0.556)
DRB1*0801 46 (2.49) 30 (6.76) <0.001 <0.001 2.832 (1.766, 4.542)
DRB1*1104 20 (1.08) 23 (5.18) <0.001 <0.001 4.982 (2.711, 9.156)
DQA1*0201 282 (15.29) 28 (6.31) <0.001 <0.001 0.373 (0.249, 0.558)
DQA1*0401 58 (3.15) 36 (8.11) <0.001 <0.001 2.717 (1.768, 4.175)
DQB1*0202 232 (12.58) 29 (6.53) <0.001 0.007 0.485 (0.325, 0.725)
DQB1*02 468 (25.38) 68 (15.32) <0.001 <0.001 0.532 (0.402, 0.703)
DQB1*0402 61 (3.31) 37 (8.33) <0.001 <0.001 2.657 (1.742, 4.054)
DQB1*0501 291 (15.78) 113 (25.45) <0.001 <0.001 1.822 (1.422, 2.336)

HLA Class II significant associations with ACAs (after 10 000-fold permutation testing) in Spain. No significant associations were found in Italy. Number of positive alleles in cases = 444 and controls = 1844. Ctrl: controls.